AU537689B2 - Stabilized radiographic scanning agents - Google Patents

Stabilized radiographic scanning agents

Info

Publication number
AU537689B2
AU537689B2 AU45595/79A AU4559579A AU537689B2 AU 537689 B2 AU537689 B2 AU 537689B2 AU 45595/79 A AU45595/79 A AU 45595/79A AU 4559579 A AU4559579 A AU 4559579A AU 537689 B2 AU537689 B2 AU 537689B2
Authority
AU
Australia
Prior art keywords
acid
gentisate
applicant
salts
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU45595/79A
Other languages
English (en)
Other versions
AU4559579A (en
Inventor
Mahdi Bakir Fawzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU4559579A publication Critical patent/AU4559579A/en
Application granted granted Critical
Publication of AU537689B2 publication Critical patent/AU537689B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU45595/79A 1978-03-31 1979-03-29 Stabilized radiographic scanning agents Expired AU537689B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US892245 1978-03-31
US05/892,245 US4233284A (en) 1978-03-31 1978-03-31 Stabilized radiographic scanning agents

Publications (2)

Publication Number Publication Date
AU4559579A AU4559579A (en) 1979-10-04
AU537689B2 true AU537689B2 (en) 1984-07-05

Family

ID=25399629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45595/79A Expired AU537689B2 (en) 1978-03-31 1979-03-29 Stabilized radiographic scanning agents

Country Status (11)

Country Link
US (1) US4233284A (enExample)
EP (1) EP0004684B1 (enExample)
JP (2) JPS5513258A (enExample)
AU (1) AU537689B2 (enExample)
CA (1) CA1122524A (enExample)
DE (1) DE2960805D1 (enExample)
DK (1) DK156411C (enExample)
IE (1) IE48095B1 (enExample)
NZ (1) NZ190089A (enExample)
PH (1) PH16295A (enExample)
ZA (1) ZA791470B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247534A (en) * 1978-07-31 1981-01-27 The Procter & Gamble Company Radiographic scanning agent
US4515766A (en) * 1980-06-23 1985-05-07 The Massachusetts General Hospital Labeled phosphonic acid compositions for investigations of in vivo deposits of calcium
JPS5750928A (en) * 1980-09-13 1982-03-25 Nippon Mejifuijitsukusu Kk Diagnostic agent for scanning bone
DE3274621D1 (en) * 1981-10-30 1987-01-22 Amersham Int Plc Radiopharmaceutical composition based on technetium-99m and reagent for making it
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
US4504463A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
US4504462A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
DE3370443D1 (en) 1982-06-10 1987-04-30 Mallinckrodt Inc Radiographic imaging agents
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4510125A (en) * 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
DE3331159A1 (de) * 1983-08-30 1985-03-14 Hoechst Ag, 6230 Frankfurt N-(4-aminobenzoyl)-aminodicarbonsaeuren zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung
US4582700A (en) * 1983-09-01 1986-04-15 Mallinckrodt, Inc. Products and processes
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5556982A (en) * 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
JPS61286452A (ja) * 1985-06-13 1986-12-17 株式会社イナックス 長尺建築部材カバー及びその取付方法
DE3780820D1 (enExample) * 1987-10-30 1992-09-03 Sorin Biomedica S.P.A., Saluggia, Vercelli, It
US5202109A (en) * 1988-06-10 1993-04-13 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US5089249A (en) * 1988-06-10 1992-02-18 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US4880615A (en) * 1988-11-25 1989-11-14 Merck & Co., Inc. Stabilized radiopharmaceutical compositions
US6359119B1 (en) * 2000-05-24 2002-03-19 Mallinckrodt Inc. Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
US6902718B2 (en) * 2000-10-24 2005-06-07 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers
US6881396B2 (en) 2000-10-24 2005-04-19 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans
US6989138B2 (en) 2000-10-24 2006-01-24 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
WO2003092743A1 (en) * 2002-05-03 2003-11-13 Bracco Imaging S.P.A. Radiopharmaceutical formulations
EP1444990A1 (en) * 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions
GB0514087D0 (en) * 2005-07-11 2005-08-17 Ge Healthcare Ltd Stabilised radiopharmaceutical compositions
EP2214722A1 (en) * 2007-11-07 2010-08-11 GE Healthcare BV Stabilization of radiopharmaceuticals
WO2011147762A2 (en) 2010-05-25 2011-12-01 Bayer Pharma Aktiengesellschaft Stabilized radiopharmaceutical composition
BR112020005243A2 (pt) 2017-11-23 2020-09-24 Jubilant Generics Limited (Formerly A Division Of Jubilant Life Sciences Limited) composição farmacêutica compreendendo tetrofosmina e sais farmaceuticamente aceitáveis da mesma
WO2021032784A1 (en) 2019-08-19 2021-02-25 Nuclear Research And Consultancy Group Platinum isotope combined with bone-targeting agents for use in anticancer drugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987157A (en) * 1974-08-29 1976-10-19 Union Carbide Corporation Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation
ZA761944B (en) * 1975-04-30 1977-03-30 Procter & Gamble Stable radiographic scanning agents
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
DE2543350C2 (de) * 1975-09-29 1984-10-11 Henkel KGaA, 4000 Düsseldorf Präparate zur Herstellung von ↑9↑↑9↑↑m↑ Technetium-Radiodiagnostika
DE2543349C2 (de) * 1975-09-29 1984-05-10 Henkel KGaA, 4000 Düsseldorf Preaparate zur herstellung von99m technetium-radiagnostica
US4071613A (en) * 1976-02-26 1978-01-31 Abbott Laboratories Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
US4075314A (en) * 1976-04-29 1978-02-21 Mallinckrodt, Inc. Stannous pyrophosphate technetium-99m compositions

Also Published As

Publication number Publication date
DK133979A (da) 1979-10-01
JPS61210042A (ja) 1986-09-18
EP0004684A3 (en) 1979-11-14
DK156411B (da) 1989-08-21
DE2960805D1 (en) 1981-12-03
ZA791470B (en) 1980-05-28
JPS5513258A (en) 1980-01-30
US4233284A (en) 1980-11-11
JPH0149329B2 (enExample) 1989-10-24
NZ190089A (en) 1981-11-19
CA1122524A (en) 1982-04-27
IE790659L (en) 1979-09-30
EP0004684B1 (en) 1981-09-16
JPS6148485B2 (enExample) 1986-10-24
AU4559579A (en) 1979-10-04
DK156411C (da) 1990-01-22
IE48095B1 (en) 1984-09-19
EP0004684A2 (en) 1979-10-17
PH16295A (en) 1983-09-05

Similar Documents

Publication Publication Date Title
AU522235B2 (en) Radioactive scanning agents
AU4559579A (en) Stabilized radiographic scanning agents
AU515772B2 (en) "15-deoxy-16-hydroxyprostaglandins"
AU511735B2 (en) Spiro-4'-piperidino compounds
JPS5554439A (en) Scanning agent for radiography
AU523295B2 (en) X-ray contrast agent
GB2035748B (en) Radiography
JPS5560444A (en) Scanner for computerrtomography
AU529330B2 (en) Piperazinylbenzoheterocyclic compounds
JPS552487A (en) Tomographic scanner
AU526183B2 (en) Sulfonato-organosilanol compounds
JPS54159434A (en) Positionnselectable glassssurface temperaturee scanner
AU528403B2 (en) Flukicidal compounds
AU4328579A (en) Subsoiler
GB2027696B (en) X-ray contrast agents
IL57359A (en) Beam
AU520081B2 (en) Furonaphthyridine compounds
GB2038150B (en) Radiography
JPS551599A (en) Scanner
AU4568879A (en) Biologically active compounds
JPS5589866A (en) Scanning unit
AU531535B2 (en) Oxothia compounds
AU529275B2 (en) Lactyl tetrapeptide
AU517623B2 (en) Substituted 2-phenyl-imidazolines-(2)
SU694500A1 (ru) Хлоргидрат 1-фенилселено-4-фенил-4-гексаметилениминобутина-2, обладающий биоантиоксидантным действием